VBI Vaccines Financials
| VBIVQ Stock | 0.0005 0.0001 16.67% |
The essential information of the day-to-day investment outlook for VBI Vaccines includes many different criteria found on its balance sheet. An individual investor should monitor VBI Vaccines' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in VBI Vaccines.
Net Income |
|
VBI | Select Account or Indicator |
VBI Vaccines Stock Summary
VBI Vaccines competes with Kura Sushi, Awilco Drilling, Transocean, Westrock Coffee, and Patterson UTI. VBI Vaccines is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| Business Address | 160 Second Street, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.vbivaccines.com |
| Phone | 617 830 3031 |
VBI Vaccines Key Financial Ratios
| Revenue | 8.68 M | ||||
| Net Income | (92.84 M) | ||||
| Total Asset | 86.95 M | ||||
| Retained Earnings | (582.45 M) |
VBI Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VBI Vaccines's current stock value. Our valuation model uses many indicators to compare VBI Vaccines value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VBI Vaccines competition to find correlations between indicators driving VBI Vaccines's intrinsic value. More Info.VBI Vaccines is rated first in revenue category among its peers. It is rated first in net income category among its peers . At this time, VBI Vaccines' Total Revenue is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value VBI Vaccines by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.VBI Vaccines Systematic Risk
VBI Vaccines' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. VBI Vaccines volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on VBI Vaccines correlated with the market. If Beta is less than 0 VBI Vaccines generally moves in the opposite direction as compared to the market. If VBI Vaccines Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one VBI Vaccines is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of VBI Vaccines is generally in the same direction as the market. If Beta > 1 VBI Vaccines moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as VBI Vaccines is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of VBI has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if VBI Vaccines' financials are consistent with your investment objective using the following steps:- Review VBI Vaccines' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand VBI Vaccines' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare VBI Vaccines' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if VBI Vaccines' stock is overvalued or undervalued.
VBI Vaccines December 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of VBI Vaccines help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of VBI Vaccines. We use our internally-developed statistical techniques to arrive at the intrinsic value of VBI Vaccines based on widely used predictive technical indicators. In general, we focus on analyzing VBI Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build VBI Vaccines's daily price indicators and compare them against related drivers.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 177.78 | |||
| Value At Risk | (50.00) | |||
| Potential Upside | 60.0 |
Additional Tools for VBI Stock Analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.